Eli Lilly and Company Total Liabilities 2011-2026 | LLY

Annual Total Liabilities Eli Lilly and Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	36.6 B	33 B	33.3 B	24.7 B	21 B	21.8 B	17.6 B	19.6 B	20.1 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.6 B	17.6 B	25.3 B

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Akari Therapeutics, Plc AKTX	19.6 M	$ 5.12	11.55 %	$ 345 B	Britain
Alterity Therapeutics Limited ATHE	5.89 M	$ 3.97	6.43 %	$ 9.55 B	Australia
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	4.18 B	$ 320.13	-3.98 %	$ 41.9 B	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	1.45 B	$ 4.67	-1.27 %	$ 766 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	35 M	$ 7.66	3.23 %	$ 75.7 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	840 M	$ 21.81	0.6 %	$ 1.02 B	USA
CymaBay Therapeutics CBAY	142 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	2.76 B	-	-	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Cabaletta Bio CABA	53 M	$ 3.52	3.53 %	$ 354 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.08	-2.84 %	$ 5.07 M	Israel
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	32.5 M	-	-5.16 %	$ 5.39 M	USA
Galectin Therapeutics GALT	146 M	$ 2.26	-11.72 %	$ 144 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	344 M	$ 1.35	-12.9 %	$ 347 M	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	194 M	$ 4.26	0.47 %	$ 456 M	USA
Grifols, S.A. GRFS	12.8 B	$ 8.6	-1.04 %	$ 6.83 B	Spain
Arcutis Biotherapeutics ARQT	243 M	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	411 M	$ 1.61	8.05 %	$ 428 M	Britain
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	5.68 M	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	49.9 M	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	55.8 M	$ 33.86	-0.03 %	$ 2.25 B	USA